* 香港富豪李嘉诚家族旗下从事葡萄园出租与癌症疫苗研发的长江生命科技0775.HK周三早盘涨幅扩大至13.2%，创2022年12月13日以来新高。
* 该公司此前公告称，对研发中之癌症疫苗，就针对PRAME、PD-L1、B7-H3及Claudin 6 蛋白质之临床前成效结果感到满意，亦对利用人工智能$(AI)$平台设计癌症疫苗的进度甚感欣慰。
* 长江生命科技今年迄今暴涨109.8%，同期恒生指数.HSI上扬10%。
* 恒生香港上市生物科技指数.HSHKBIO盘中一度升3.8%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 田镧沁)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.